Home / About the initiative

About the initiative

What is Cardiomyopathies Matter?

Cardiomyopathies Matter is a multi-stakeholder initiative funded by Bristol Myers Squibb that aims to raise awareness of cardiomyopathies among policy-makers and to ensure these health conditions are given the policy attention they warrant both at national and EU levels.

Specifically, the initiative provides a platform for stakeholders to collaborate to:

  • inform policymakers about cardiomyopathies and their impact on individuals, societies and healthcare systems
  • identify key challenges and unmet needs
  • offer policy recommendations to improve patient outcomes, for example by supporting early diagnosis, access to optimal care, and innovation.